Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution that acts as a stimulant laxative by drawing water into the colon and stimulating bowel evacuation.
## Primary Indications
* Bowel preparation for diagnostic procedures (e.g., sigmoidoscopy, colonoscopy).
* Relief of occasional constipation.
## Adult Dosing
* **Bowel preparation:** Typically, one 4.5 oz (133 mL) bottle administered 3-5 hours before the procedure. Do not exceed 1 bottle in 24 hours.
* **Constipation:** One 2.25 oz (66 mL) bottle administered as a single dose. Do not exceed 1 bottle in 24 hours.
## Pediatric Dosing
* **Children 5-11 years:** One 2.25 oz (66 mL) bottle.
* **Children under 5 years:** Not recommended. Use with extreme caution and under strict medical supervision due to increased risk of serious adverse effects.
## Dose Adjustments
No dose adjustments are typically necessary for renal or hepatic impairment, but caution is advised due to potential electrolyte disturbances.
## Contraindications
* Congenital megacolon.
* Heart failure.
* Gastrointestinal obstruction or perforation.
* Anuria.
* Children under 5 years of age (except under strict medical supervision).
* Patients with impaired renal function or those on medications that affect renal function (e.g., diuretics, ACE inhibitors, ARBs) due to the risk of hyperphosphatemia, hypocalcemia, and acute kidney injury.
## Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, bloating, anal irritation.
* **Serious:**
* **Electrolyte disturbances:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia. This is a significant concern, especially in children, the elderly, and patients with renal impairment. Symptoms can include muscle cramps, tetany, cardiac arrhythmias, seizures.
* **Acute kidney injury (AKI):** Can occur due to dehydration and electrolyte shifts.
* **Colonic perforation:** Rare but serious complication.
## Key Drug Interactions
* **Diuretics, ACE inhibitors, ARBs, NSAIDs:** Increased risk of hyperphosphatemia, hypocalcemia, and AKI.
* **Calcium and Vitamin D supplements:** May exacerbate hyperphosphatemia.
## Monitoring
* Assess for signs and symptoms of dehydration and electrolyte imbalance (e.g., thirst, dry mouth, dizziness, muscle cramps, confusion, irregular heartbeat).
* Monitor renal function (BUN, creatinine) and electrolytes (phosphate, calcium, sodium, potassium) especially in high-risk patients.
## Clinical Pearls
* Administer slowly to minimize cramping.
* Ensure adequate hydration before and after administration.
* Advise patients to call their healthcare provider if they experience severe abdominal pain, rectal bleeding, or no bowel movement within 24 hours of use.
* Due to the risk of severe electrolyte abnormalities and AKI, sodium phosphate enemas are often not the preferred agent for bowel preparation in patients with pre-existing renal disease, heart failure, or those taking interacting medications. Alternatives should be considered.
***
*Disclaimer: This information is intended for clinical use and does not substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.*
